Skip to main content
ENLV
NASDAQ Life Sciences

Enlivex Receives Nasdaq Minimum Bid Price Non-Compliance Notice

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.721
Mkt Cap
$171.057M
52W Low
$0.66
52W High
$2.1
52W Position info
9.2% above low
Off High info
66% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

ENLV is trading near its 52-week low of $0.66 (9.2% above the low).

Summary

Enlivex Ltd. has received a Nasdaq notice for failing to meet the minimum $1.00 bid price requirement, initiating a 180-day period to regain compliance and avoid potential delisting.


Key Events · Corporate Governance and Compliance · ENLV

  • Nasdaq Minimum Bid Price Non-Compliance

    Enlivex received a notice from Nasdaq for failing to maintain a minimum bid price of $1.00 for 30 consecutive business days.

  • 180-Day Compliance Period

    The company has until November 9, 2026, to regain compliance by having its stock close at or above $1.00 for at least 10 consecutive business days.

  • Potential Delisting Risk

    Failure to meet the requirement could lead to an additional compliance period (potentially requiring a reverse stock split) or, ultimately, delisting from Nasdaq.


Analysis · ENLV · Life Sciences

Enlivex has received a formal notice from Nasdaq indicating its ordinary shares have traded below the $1.00 minimum bid price for 30 consecutive business days. This triggers a 180-day compliance period, during which the company must maintain a closing bid price of at least $1.00 for 10 consecutive business days to avoid potential delisting. While there is no immediate impact on trading, failure to regain compliance could lead to a reverse stock split or, ultimately, delisting from Nasdaq.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 48.1% of the 1752 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ENLV was trading at $0.72 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $171.1M. The 52-week trading range was $0.66 to $2.10. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ENLV - Latest Insights

ENLV
Nov 02, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.90
Real-time Price: $1.21 info
Change: -$0.6884 (-36%) info
Market Cap: $1.856M info
ENLV
Oct 27, 2026, 8:59 AM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $0.1722
Real-time Price: $1.21 info
Change: Reverse Stock Split info
Market Cap: $1.856M info
ENLV
Oct 27, 2026, 8:01 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.1722
Real-time Price: $1.21 info
Change: Reverse Stock Split info
Market Cap: $1.856M info
ENLV
Oct 22, 2026, 5:17 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.59
Real-time Price: $1.21 info
Change: Reverse Stock Split info
Market Cap: $1.856M info
ENLV
Oct 19, 2026, 8:18 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.215914
Real-time Price: $1.21 info
Change: Reverse Stock Split info
Market Cap: $1.856M info